Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Acumen Pharmaceuticals Inc. is a venture-backed, pre-clinical biotech company focused on developing the first effective therapeutics and diagnostics for Alzheimer’s disease and other memory-related disorders. Founded in 1996, Acumen owns or has licensed the critical patents underlying the ADDL mechanism now widely believed to cause Alzheimer’s disease. In addition to ELISA-based diagnostic, Acumen has several therapeutic approaches to stop ADDL-related diseases. NeuroVentures LLC has made a seed investment in the company. ( www.acumenpharm.com )
Acumen Pharmaceuticals , Inc.
385 Oyster Point Blvd. Suite 9A
South San Francisco, California 94080
USA
Tel: (650) 875-7700
Fax: (650) 875-7772